03/10/2014 | Mark Hillen
Aflibercept gets approved by NICE, STAAR’s Visian ICL with CentraFLOW gets approved in Japan, and rises and falls in Allergan and Alcon’s revenues.
Acucela prices its initial public offering on the Tokyo Stock Exchange at $162M.
03/05/2014
The Ophthalmologist Travel Award represents a great opportunity: the chance of a free trip to the AAO 2014 congress in Chicago – flights, accommodation, and congress registration fees, in return for a chronic DME case study.
02/11/2014 | Gullapalli Rao
At the age of 39, I left a satisfying career in the United States to follow a dream of building a world-class eye institute in my native India.
02/11/2014
Sitting Down With Walter Wrobel, CEO/ President, and Reinhard Rubow, CFO, Retina Implant AG
02/11/2014 | Mark Hillen
Electronic patient education systems look great, offer flexibility in what’s communicated and can be branded with your logo. Goodbye textbooks!
02/10/2014 | Laura Hobbs
Realizing the full potential of your cataract/ refractive practice starts with marketing… but it doesn’t stop there.
02/10/2014 | Mark Hillen
Medscape assessed the lifestyles of physicians; of the twenty-six specialties covered, ophthalmologists have the most to boast about.
Carl Zeiss and Aaren buy, Alimera raise working capital and Novo A/S make a milestone payment to Ophthotech for Fovista.
02/10/2014 | Richard Gallagher
Be it battling blindness one patient at a time or changing global healthcare policies, ophthalmologists demonstrate admirable altruism.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: